ImageneBio (IMA) Amortizatization of Intangibles (2023 - 2025)
ImageneBio's (IMA) quarterly Amortizatization of Intangibles came in at -$210000.0 in Q3 2025, up 58.33% year-on-year from -$132631.6 in Q3 2024, and down 186.42% quarter-over-quarter from $243000.0 in Q2 2025.
ImageneBio (IMA) Amortizatization of Intangibles (2023 - 2025) Analysis & Trends
ImageneBio has disclosed Amortizatization of Intangibles across 3 years of filings, most recently posting -$210000.0 for Q3 2025.
- Amortizatization of Intangibles for Q3 2025 came in at -$210000.0, up 58.33% year-over-year; the trailing twelve-month figure through Sep 2025 was $1.2 million (up 89.47% YoY), and the FY2024 annual result was $1.5 million, down 27.43% from the prior year.
- Amortizatization of Intangibles came in at -$210000.0 for Q3 2025 at ImageneBio, down from $243000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.2 million in Q4 2024 to a low of -$504000.0 in Q3 2024.
- The 3-year median for Amortizatization of Intangibles is $408500.0 (2024), against an average of $352400.0.
- Peak annual rise in Amortizatization of Intangibles reached 267.83% in 2024, while the deepest fall reached 187.35% in 2024.
- ImageneBio's Amortizatization of Intangibles stood at $314000.0 in 2023, then soared by 267.83% to $1.2 million in 2024, then plunged by 118.18% to -$210000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at -$210000.0 (Q3 2025), $243000.0 (Q2 2025), and $1.2 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | ImageneBio | 3.18 Mn | 3.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -210,000.00 |
| Sep 30, 2025 | -210,000.00 |
| Jun 30, 2025 | 243,000.00 |
| Jun 30, 2025 | 243,000.00 |
| Dec 31, 2024 | 1.16 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | -504,000.00 |
| Sep 30, 2024 | -504,000.00 |
| Jun 30, 2024 | 424,000.00 |
| Jun 30, 2024 | 424,000.00 |
| Mar 31, 2024 | 393,000.00 |
| Mar 31, 2024 | 393,000.00 |
| Dec 31, 2023 | 314,000.00 |
| Dec 31, 2023 | 314,000.00 |
| Sep 30, 2023 | 577,000.00 |
| Sep 30, 2023 | 577,000.00 |
| Jun 30, 2023 | 602,000.00 |
| Jun 30, 2023 | 602,000.00 |
| Mar 31, 2023 | 530,000.00 |
| Mar 31, 2023 | 530,000.00 |